Critics urge Novo Nordisk to reconsider pricing strategy for Ozempic
Novo Nordisk, the maker of the popular weight loss drug Ozempic, is facing increasing pressure over its pricing strategy. The company has been under scrutiny for the high cost of the drug, which can be a deterrent for patients seeking treatment.